1. Home
  2. ARTNA vs GLUE Comparison

ARTNA vs GLUE Comparison

Compare ARTNA & GLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTNA
  • GLUE
  • Stock Information
  • Founded
  • ARTNA 1905
  • GLUE 2019
  • Country
  • ARTNA United States
  • GLUE United States
  • Employees
  • ARTNA N/A
  • GLUE N/A
  • Industry
  • ARTNA Water Supply
  • GLUE Biotechnology: Pharmaceutical Preparations
  • Sector
  • ARTNA Utilities
  • GLUE Health Care
  • Exchange
  • ARTNA Nasdaq
  • GLUE Nasdaq
  • Market Cap
  • ARTNA 343.5M
  • GLUE 351.2M
  • IPO Year
  • ARTNA 1996
  • GLUE 2021
  • Fundamental
  • Price
  • ARTNA $33.15
  • GLUE $4.80
  • Analyst Decision
  • ARTNA
  • GLUE Buy
  • Analyst Count
  • ARTNA 0
  • GLUE 2
  • Target Price
  • ARTNA N/A
  • GLUE $13.50
  • AVG Volume (30 Days)
  • ARTNA 28.6K
  • GLUE 369.2K
  • Earning Date
  • ARTNA 08-04-2025
  • GLUE 08-07-2025
  • Dividend Yield
  • ARTNA 3.71%
  • GLUE N/A
  • EPS Growth
  • ARTNA 22.07
  • GLUE N/A
  • EPS
  • ARTNA 2.17
  • GLUE 0.29
  • Revenue
  • ARTNA $110,427,000.00
  • GLUE $177,986,000.00
  • Revenue This Year
  • ARTNA $6.86
  • GLUE $83.76
  • Revenue Next Year
  • ARTNA $4.46
  • GLUE N/A
  • P/E Ratio
  • ARTNA $15.28
  • GLUE $16.32
  • Revenue Growth
  • ARTNA 7.13
  • GLUE 2990.57
  • 52 Week Low
  • ARTNA $29.45
  • GLUE $3.50
  • 52 Week High
  • ARTNA $38.94
  • GLUE $12.40
  • Technical
  • Relative Strength Index (RSI)
  • ARTNA 48.19
  • GLUE 51.69
  • Support Level
  • ARTNA $33.00
  • GLUE $4.54
  • Resistance Level
  • ARTNA $34.28
  • GLUE $4.93
  • Average True Range (ATR)
  • ARTNA 0.66
  • GLUE 0.21
  • MACD
  • ARTNA 0.01
  • GLUE 0.06
  • Stochastic Oscillator
  • ARTNA 36.90
  • GLUE 81.43

About ARTNA Artesian Resources Corporation

Artesian Resources Corp operates as a holding company with a focus on water distribution and wastewater services. Its regulated utility segment includes subsidiaries providing water and wastewater services in Delaware, Maryland, and Pennsylvania. Water distribution spans residential, commercial, industrial, and municipal sectors, while wastewater services are offered in Sussex County, Delaware. The company also engages in non-utility businesses, offering service line protection plans, engineering services, and contract operations for water and wastewater systems. The regulated utility segment constitutes the portion of the company's operations, subject to regulations by Delaware, Maryland, and Pennsylvania.

About GLUE Monte Rosa Therapeutics Inc.

Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in MYC-driven tumors. The company's focus lies in advancing its pipeline of MGDs, aiming to provide novel therapeutic modalities for various diseases.

Share on Social Networks: